Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort
出版年份 2015 全文链接
标题
Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort
作者
关键词
Acromegaly, Health-related quality of life, Pegvisomant, Growth hormone, IGF-1
出版物
Pituitary
Volume 18, Issue 6, Pages 916-923
出版商
Springer Nature
发表日期
2015-07-29
DOI
10.1007/s11102-015-0673-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels
- (2014) Michael Droste et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: A study on 184 patients
- (2014) Kostas Lampropoulos et al. Hormones-International Journal of Endocrinology and Metabolism
- Somatostatin receptors: From signaling to clinical practice
- (2013) Marily Theodoropoulou et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register
- (2012) Christof Schöfl et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
- (2012) A. J. van der Lely et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pegvisomant and cabergoline combination therapy in acromegaly
- (2012) I. Bernabeu et al. Pituitary
- Self-perceived quality of life predicts mortality risk better than a multi-biomarker panel, but the combination of both does best
- (2011) Robin Haring et al. BMC Medical Research Methodology
- Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
- (2011) John A. Jane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults
- (2010) Edna J L Barbosa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patients
- (2010) J Roemmler et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register
- (2009) S. Petersenn et al. CLINICAL ENDOCRINOLOGY
- Sex-related psychological effects on metabolic control in type 2 diabetes mellitus
- (2009) G. Kacerovsky-Bielesz et al. DIABETOLOGIA
- Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study
- (2009) M Buchfelder et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Which patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY
- (2009) Thierry Brue et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The German ACROSTUDY: past and present
- (2009) M Buchfelder et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008
- (2009) Ali Montazeri Health and Quality of Life Outcomes
- Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly
- (2009) Marily Theodoropoulou et al. INTERNATIONAL JOURNAL OF CANCER
- The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
- (2009) Ignacio Bernabeu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Are health-related quality-of-life and self-rated health associated with mortality? Insights from Translating Research Into Action for Diabetes (TRIAD)
- (2009) Laura N. McEwen et al. Primary Care Diabetes
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started